Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

05/11/2020 04:30

Nov 5 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.79               45.17            77.20    
                 (-18.6 pct)         (-4.9 pct)       (-13.5 pct) 
  Operating          9.78               13.74            18.10    
                 (-28.8 pct)         (+11.2 pct)      (-31.7 pct) 
  Recurring         10.01               13.93            18.50    
                 (-28.1 pct)         (+11.1 pct)      (-31.3 pct) 
  Net                7.23                9.55            13.40    
                 (-24.3 pct)         (+8.0 pct)       (-30.8 pct) 
  EPS            186.15 yen          242.56 yen       348.06 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T